However, in premenopausal women treated with ovarian function suppression or ablation, another efficacious endocrine treatment,3 this physiological response is overcome and aromatase inhibitors might, therefore, also be more efficacious than tamoxifen at preventing breast cancer recurrence.4 This evidence concerns the gene CYP19A1 and breast carcinoma.